## Answer
(model generated chain of thought explanation)

Given the patient's presentation of blood in his urine, lower abdominal pain, urinary frequency and urgency, and recent chemotherapy for non-Hodgkin lymphoma, we need to consider which medication from the options provided is most likely responsible.

Firstly, let's evaluate each option:

A. Methotrexate - This is a chemotherapeutic agent used in various cancers, including leukemia and lymphomas. However, it is not commonly associated with urinary frequency and urgency as a primary side effect.

B. Rituximab - This is a monoclonal antibody used primarily for the treatment of non-Hodgkin lymphoma. While rituximab can cause various side effects, such as infusion-related reactions, fatigue, and mucositis, it is not typically associated with urinary frequency and urgency.

C. Cyclophosphamide - This is another chemotherapeutic agent commonly used in the treatment of non-Hodgkin lymphoma. One of its notable side effects is hemorrhagic cystitis, which can cause blood to appear in the urine due to damage to the bladder lining. Additionally, cyclophosphamide can also cause urinary frequency and urgency.

D. Prednisone - This corticosteroid is often used as part of chemotherapy regimens to reduce inflammation and suppress the immune system. While prednisone can have various side effects, such as weight gain, mood changes, and increased blood sugar levels, it is not commonly associated with urinary frequency and urgency.

Considering these factors, the medication in the chemotherapy regimen most likely to cause the patient's symptoms is cyclophosphamide due to its association with hemorrhagic cystitis and urinary frequency/urgency.

The final answer is: C